Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Ophthalmology & ENTPRM 5676
Dosage formEye drops
Ophthalmic

Acetyl Cysteine 5% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 4630
Dosage formHard-gelatin capsules
Oral

Adenosine Triphosphate Disodium 20 mg, Idebenone 10 mg, L-Arginine 200 mg, Proanthocynidine 33 mg, Selenium 70 mcg, Zinc 10 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Mitochondrial electron-transfer / antioxidant agent + Amino acid / metabolic nutritional supplement + Antioxidant / nutritional supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 4631
Dosage formHard-gelatin capsules
Oral

Adenosine Triphosphate Disodium 30 mg, Aescin 30 mg, Idebenone 15 mg, Methylcobalamin 750 mcg, Proanthocynidine 50 mg, Selenium 70 mcg, Zinc 10 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Mitochondrial electron-transfer / antioxidant agent + Venotonic / capillary-stabilising agent + Antioxidant / nutritional supplement + Vitamin / mineral supplement + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5677
Dosage formEye drops
Ophthalmic

Alcaftadine 0.25% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5678
Dosage formEye drops
Ophthalmic

Alcaftadine 0.25% w/v, Ketorolac Tromethamine 0.4% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
H1 antihistamine + NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5679
Dosage formEye drops
Ophthalmic

Atropine Sulfate 0.1 mg, Polyhexamethylene Biguanide Hcl 0.05 mg / ml

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Antimuscarinic mydriatic / cycloplegic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5680
Dosage formEye drops
Ophthalmic

Azelastine 0.5 mg / ml

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5827
Dosage formNasal drops
Intranasal

Azelastine Hcl 0.1% w/v, Benzalkonium Chloride Solution 0.025% w/v

Route
Intranasal
Formulation type
Nasal liquid preparation
Pharmacological class
H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5828
Dosage formNasal drops
Intranasal

Azelastine Hcl 0.10% w/v, Benzalkonium Chloride 0.02% w/v, Fluticasone Furoate 0.02% w/v

Route
Intranasal
Formulation type
Nasal liquid preparation
Pharmacological class
Corticosteroid + H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5681
Dosage formEye drops
Ophthalmic

Azithromycin 1%

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Macrolide antibiotic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 0021
Dosage formEar drops
Otic

Beclomethasone Dipropionate 0.025% w/v, Clotrimazole 1% w/v, Gentamicin 0.3% w/v, Lignocaine 2% w/v

Route
Otic
Formulation type
Otic liquid drops
Pharmacological class
Antifungal
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5816
Dosage formEar drops
Otic

Beclomethasone Dipropionate 0.025% w/v, Clotrimazole 1% w/v, Lignocaine 2% w/v, Neomycin Sulphate 0.5% w/v

Route
Otic
Formulation type
Otic liquid drops
Pharmacological class
Aminoglycoside antibiotic + Azole antifungal + Corticosteroid + Local anaesthetic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5682
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.004% w/v, Borax 0.2% w/v, Boric Acid 2.0% w/v, Menthol 0.005% w/v, Zinc Sulphate 0.0004% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Ophthalmic electrolyte / astringent preparation
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5683
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.01% w/v, Boric Acid 1.25% w/v, Chlorpheniramine Maleate 0.2% w/v, Hydroxypropylmethyl Cellulose 0.3% w/v, Phenylephrine Hcl 0.12% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Adrenergic decongestant + H1 antihistamine + Ophthalmic lubricant / tear substitute
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5684
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.01% w/v, Ciprofloxacin Hcl 0.3% w/v, Hydroxypropylmethylcellulose 0.25% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Ophthalmic lubricant / tear substitute + Quinolone antibiotic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5685
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.01% w/v, Homatropine Hbr 1% w/v, Phenylephrine Hcl 5% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Adrenergic decongestant + Antimuscarinic mydriatic / cycloplegic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5686
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.01% w/v, Ketorolac Tromethamine 0.4% w/v, Moxifloxacin Hcl 0.5% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
NSAID analgesic + Quinolone antibiotic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5687
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.01% w/v, Phenylephrine Hcl 50 mg, Tropicamide 8 mg

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
Adrenergic decongestant + Antimuscarinic mydriatic / cycloplegic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5829
Dosage formNasal drops
Intranasal

Benzalkonium Chloride 0.01% w/v, Sodium Chloride 0.74% w/v

Route
Intranasal
Formulation type
Nasal liquid preparation
Pharmacological class
Saline nasal moisturiser
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5830
Dosage formNasal drops
Intranasal

Benzalkonium Chloride 0.01% w/v, Sorbitol Solution 2% w/v, Xylometazoline Hcl 0.05% w/v

Route
Intranasal
Formulation type
Nasal liquid preparation
Pharmacological class
Adrenergic decongestant
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5688
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.015% w/v, Olopatadine Hcl 0.7% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5831
Dosage formNasal drops
Intranasal

Benzalkonium Chloride 0.02% v/v, Xylometazoline Hcl 0.1% w/v

Route
Intranasal
Formulation type
Nasal liquid preparation
Pharmacological class
Adrenergic decongestant
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5689
Dosage formEye drops
Ophthalmic

Benzalkonium Chloride 0.05 mg, Ketorolac Tromethamine 4.00 mg, Olopatadine 1.00 mg

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
H1 antihistamine + NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5832
Dosage formNasal drops
Intranasal

Benzalkonium Chloride 0.1% w/v, Sorbitol Solution 2% w/v, Xylometazoline Hcl 0.1% w/v

Route
Intranasal
Formulation type
Nasal liquid preparation
Pharmacological class
Adrenergic decongestant
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product